|
Follow the links below to find summaries of systematic reviews of the evidence for the effectiveness of treatments for ovarian cancer.
Reviewed February 2010
Printer friendly page
| Results 1 to 9 displayed. |
| Title: |
Antigen-specific active immunotherapy for ovarian cancer
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
Epithelial ovarian cancer is the most frequently diagnosed ovarian malignancy and the leading cause of death from gynaecological cancers. Standard therapy consists of surgery followed by chemotherapy. Although initial response rates are high, the majori...
|
| Date: |
Oct 2009
|
| Title: |
Interval debulking surgery for advanced epithelial ovarian cancer
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
Ovarian cancer frequently presents at an advanced stage so it may not be possible to remove all tumours during surgery. Several cycles of chemotherapy are generally given after primary surgery. Secondary surgery, performed after a few cycles of chemothe...
|
| Date: |
Feb 2009
|
| Title: |
Laparoscopy versus laparotomy for FIGO Stage I ovarian cancer
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
Controversial discussion has arisen among endoscopists and oncologists about the laparoscopic management of early stage ovarian tumours. This systematic review found no evidence to help quantify the value of laparoscopy for the management of early stage...
|
| Date: |
Jul 2008
|
| Title: |
Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
Chemotherapy with platinum containing drugs given after surgery to remove ovarian cancers that have not spread beyond the pelvis saves lives but is probably unnecessary when the tumour is proven to have not spread outside of the ovary, particularly if t...
|
| Date: |
Jun 2008
|
| Title: |
Topotecan for ovarian cancer
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
It appears to have a similar level of effectiveness as paclitaxel and pegylated liposomal doxorubicin, though with different patterns of side effects. Larger, well-designed randomised controlled trials (RCTs) are required to define an optimal regime. ...
|
| Date: |
Feb 2008
|
| Title: |
Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancer
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
Epithelial ovarian cancer is the sixth commonest cancer world-wide and is the commonest form of ovarian cancer (approximately 90% of ovarian cancers). Unfortunately most women with ovarian cancer (75%) present at a late stage when their disease has spre...
|
| Date: |
Jul 2007
|
| Title: |
Tamoxifen for relapse of ovarian cancer
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
Ovarian cancer often spreads before symptoms show. Cytotoxic drugs are often only partly effective and cause severe side-effects. The main aims of treatment for relapsed disease are symptom control and prolongation of life. Tamoxifen has few side-effect...
|
| Date: |
Feb 2002
|
| Title: |
Chemotherapy for advanced ovarian cancer
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
Ovarian cancer is the seventh commonest female cancer worldwide. Single-drug or combination chemotherapy is used routinely to treat it. This review found a small benefit in platinum-based chemotherapy over non-platinum therapy. It also found that platin...
|
| Date: |
Sep 1998
|
| Results 1 to 9 displayed. |
|
